CA2091360A1 - Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques - Google Patents

Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques

Info

Publication number
CA2091360A1
CA2091360A1 CA2091360A CA2091360A CA2091360A1 CA 2091360 A1 CA2091360 A1 CA 2091360A1 CA 2091360 A CA2091360 A CA 2091360A CA 2091360 A CA2091360 A CA 2091360A CA 2091360 A1 CA2091360 A1 CA 2091360A1
Authority
CA
Canada
Prior art keywords
mometasone furoate
pharmaceutical compositions
making same
furoate monohydrate
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2091360A
Other languages
English (en)
Other versions
CA2091360C (fr
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2091360(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2091360A1 publication Critical patent/CA2091360A1/fr
Application granted granted Critical
Publication of CA2091360C publication Critical patent/CA2091360C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002091360A 1990-09-10 1991-09-06 Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques Expired - Lifetime CA2091360C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
US580,239 1990-09-10

Publications (2)

Publication Number Publication Date
CA2091360A1 true CA2091360A1 (fr) 1992-03-11
CA2091360C CA2091360C (fr) 1997-04-08

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091360A Expired - Lifetime CA2091360C (fr) 1990-09-10 1991-09-06 Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques

Country Status (35)

Country Link
US (1) US6180781B1 (fr)
EP (1) EP0548114B1 (fr)
JP (1) JPH0725789B2 (fr)
KR (1) KR960013445B1 (fr)
CN (1) CN1030920C (fr)
AT (1) ATE113604T1 (fr)
AU (1) AU663471B2 (fr)
BG (1) BG60755B2 (fr)
CA (1) CA2091360C (fr)
CZ (1) CZ281318B6 (fr)
DE (2) DE19875032I2 (fr)
DK (1) DK0548114T5 (fr)
EE (1) EE02962B1 (fr)
ES (1) ES2065701T3 (fr)
FI (1) FI111078B (fr)
HK (1) HK185996A (fr)
HR (1) HRP920383B1 (fr)
HU (1) HU213401B (fr)
IE (1) IE67056B1 (fr)
IL (1) IL99437A (fr)
LU (1) LU90366I2 (fr)
MX (2) MX9203396A (fr)
MY (1) MY106644A (fr)
NL (1) NL980012I2 (fr)
NO (1) NO300548B1 (fr)
NZ (1) NZ239711A (fr)
OA (1) OA09772A (fr)
PH (1) PH30443A (fr)
PL (1) PL165803B1 (fr)
PT (1) PT98905B (fr)
SI (1) SI9111497A (fr)
TW (2) TW272195B (fr)
WO (1) WO1992004365A1 (fr)
YU (1) YU48666B (fr)
ZA (1) ZA917148B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU663471B2 (en) * 1990-09-10 1995-10-12 Merck Sharp & Dohme Corp. Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
EP1033991B1 (fr) * 1997-10-09 2002-04-17 Schering Corporation Suspensions de mometasone furoate pour la nebulisation
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
EP1694655A2 (fr) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiesterase
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
WO2008111009A1 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
MX337126B (es) 2009-05-29 2016-02-12 Pearl Therapeutics Inc Administracion respiratoria de agentes activos.
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8790T1 (de) * 1981-02-02 1984-08-15 Schering Corporation Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
AU663471B2 (en) * 1990-09-10 1995-10-12 Merck Sharp & Dohme Corp. Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Also Published As

Publication number Publication date
FI111078B (fi) 2003-05-30
ZA917148B (en) 1992-08-26
TW272195B (fr) 1996-03-11
EP0548114B1 (fr) 1994-11-02
EP0548114A1 (fr) 1993-06-30
JPH0725789B2 (ja) 1995-03-22
FI931031L (fi) 1993-03-09
NL980012I2 (nl) 2004-11-01
WO1992004365A1 (fr) 1992-03-19
FI931031A0 (fi) 1993-03-09
MY106644A (en) 1995-07-31
ATE113604T1 (de) 1994-11-15
DE69104991T2 (de) 1995-04-20
OA09772A (en) 1993-11-30
BG60755B2 (bg) 1996-02-29
IL99437A0 (en) 1992-08-18
DK0548114T5 (da) 1995-01-30
US6180781B1 (en) 2001-01-30
NO930693D0 (no) 1993-02-26
CN1030920C (zh) 1996-02-07
CN1059911A (zh) 1992-04-01
PH30443A (en) 1997-05-09
DE19875032I2 (de) 2007-04-19
HUT64361A (en) 1993-12-28
PT98905B (pt) 1998-08-31
JPH05506667A (ja) 1993-09-30
TW229208B (fr) 1994-09-01
NZ239711A (en) 1992-09-25
PL165803B1 (pl) 1995-02-28
IL99437A (en) 1995-05-29
MX9100990A (es) 1992-05-04
HRP920383A2 (en) 1998-06-30
CA2091360C (fr) 1997-04-08
IE913155A1 (en) 1992-03-11
KR960013445B1 (ko) 1996-10-05
HU213401B (en) 1997-06-30
HRP920383B1 (en) 2000-04-30
NL980012I1 (nl) 1998-05-06
NO300548B1 (no) 1997-06-16
MX9203396A (es) 1992-07-31
CZ281318B6 (cs) 1996-08-14
AU8497491A (en) 1992-03-30
CZ38393A3 (en) 1994-01-19
LU90366I2 (fr) 1999-05-05
SI9111497A (sl) 1998-04-30
AU663471B2 (en) 1995-10-12
PT98905A (pt) 1992-09-30
DE69104991D1 (de) 1994-12-08
HU9300685D0 (en) 1993-06-28
EE02962B1 (et) 1997-02-17
HK185996A (en) 1996-10-11
YU48666B (sh) 1999-06-15
YU149791A (sh) 1994-01-20
IE67056B1 (en) 1996-02-21
NO930693L (no) 1993-02-26
ES2065701T3 (es) 1995-02-16

Similar Documents

Publication Publication Date Title
CA2091360A1 (fr) Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
IL100899A0 (en) Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2150251A1 (fr) Lyospheres contenant de la gonadotropine
CA2172616A1 (fr) Tropyl 7-azaindol-3-ylcarboxamides, antitussifs
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2163837A1 (fr) Hydrates de paclitaxel cristallises
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
CA2152771A1 (fr) Derives 7-o-ether de taxane
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IL98196A0 (en) Cephalosporin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL99551A0 (en) Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
HRP940315B1 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL101566A0 (en) Isoxazolylimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107359A0 (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU3101593A (en) New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it
AU6991291A (en) 3-l-(5-thioxo-l-prolyl) thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
AU3695393A (en) New arylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing it
AU5695594A (en) Thio- and oxo-azasteroids, processes for the preparation thereof, use thereof as antiandrogens and pharmaceutical compositions containing them
IL102844A0 (en) Bis-beta-ketophosphonates and bis-beta-hydroxyiminophosphonates,process for preparation and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry